Kong DL - Search Results

1

Natural products as the therapeutic strategies for addiction.

Yu R, Kong DL, Liao C, Yu YJ, He ZW, Wang Y. Yu R, et al. Among authors: kong dl. Biomed Pharmacother. 2024 Jun;175:116687. doi: 10.1016/j.biopha.2024.116687. Epub 2024 May 2. Biomed Pharmacother. 2024. PMID: 38701568 Free article. Review.

2

CircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants.

Liao C, He ZW, Yu R, Yu YJ, Liu XR, Kong DL, Wang Y. Liao C, et al. Among authors: kong dl. Arch Toxicol. 2024 May;98(5):1297-1310. doi: 10.1007/s00204-024-03706-5. Epub 2024 Mar 18. Arch Toxicol. 2024. PMID: 38498160 Review.

3

Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review.

Pan L, Meng F, Wang W, Wang XH, Shen H, Bao P, Kang J, Kong D. Pan L, et al. Front Immunol. 2023 Jan 10;13:1072612. doi: 10.3389/fimmu.2022.1072612. eCollection 2022. Front Immunol. 2023. PMID: 36703957 Free PMC article. Review.

4

A Case Report and Literature Review of Oligomeganephronia.

Wang XH, Pan L, He S, Kong DL, Wang W. Wang XH, et al. Among authors: kong dl. Front Med (Lausanne). 2022 Mar 22;9:811992. doi: 10.3389/fmed.2022.811992. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35391889 Free PMC article. Review.

5

[Corrigendum] MicroRNA‑153 attenuates hypoxia‑induced excessive proliferation and migration of pulmonary arterial smooth muscle cells by targeting ROCK1 and NFATc3.

Zhao M, Wang W, Lu Y, Wang N, Kong D, Shan L. Zhao M, et al. Mol Med Rep. 2022 Nov;26(5):332. doi: 10.3892/mmr.2022.12848. Epub 2022 Sep 9. Mol Med Rep. 2022. PMID: 36082819 Free PMC article.

6

Global research trends of obstructive sleep apnea from 2011 to 2020: a 10-year bibliometric analysis.

Pan L, Meng F, Zhang L, Shen H, Kong D, Wang W, Kang J. Pan L, et al. Ann Palliat Med. 2022 May;11(5):1671-1686. doi: 10.21037/apm-21-2237. Epub 2022 Jan 5. Ann Palliat Med. 2022. PMID: 35016523 Free article.

7

Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.

Kong D, Wang Z, Tian J, Liu T, Zhou H. Kong D, et al. J Cell Physiol. 2019 Apr;234(4):4597-4607. doi: 10.1002/jcp.27242. Epub 2018 Sep 10. J Cell Physiol. 2019. PMID: 30203548

8

MicroRNA‑153 attenuates hypoxia‑induced excessive proliferation and migration of pulmonary arterial smooth muscle cells by targeting ROCK1 and NFATc3.

Zhao M, Wang W, Lu Y, Wang N, Kong D, Shan L. Zhao M, et al. Mol Med Rep. 2021 Mar;23(3):194. doi: 10.3892/mmr.2021.11833. Epub 2021 Jan 26. Mol Med Rep. 2021. PMID: 33495839 Free PMC article.

9

Membranous Nephropathy Complicated with Disseminated Nocardia farcinica Infection: A Case Report and Literature Review.

Pan L, Wang XH, Meng FQ, Su XM, Li Y, Xu MT, Su FY, Kong DL, Wang W. Pan L, et al. Among authors: kong dl. Infect Drug Resist. 2021 Oct 8;14:4157-4166. doi: 10.2147/IDR.S331737. eCollection 2021. Infect Drug Resist. 2021. PMID: 34675560 Free PMC article.

10

Association of Obstructive Sleep Apnea with Asthma: A Meta-Analysis.

Kong DL, Qin Z, Shen H, Jin HY, Wang W, Wang ZF. Kong DL, et al. Sci Rep. 2017 Jun 22;7(1):4088. doi: 10.1038/s41598-017-04446-6. Sci Rep. 2017. PMID: 28642543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters